CA2124190A1 - Tubes de membrane foetale pour greffes nerveuses et vasculaires - Google Patents

Tubes de membrane foetale pour greffes nerveuses et vasculaires

Info

Publication number: CA2124190A1
Authority: CA; Canada
Prior art keywords: nerve; graft; proximal; amnion; distal ends
Prior art date: 1991-11-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002124190A

Other languages

English (en)

Inventor

Saleh M. Shenaq

Kathy Jo Gray

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Research Development Foundation

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-11-26

Filing date

1992-11-25

Publication date

1993-06-10

1992-11-25 Application filed by Individual filed Critical Individual

1993-06-10 Publication of CA2124190A1 publication Critical patent/CA2124190A1/fr

Status Abandoned legal-status Critical Current

Links

210000005036 nerve Anatomy 0.000 title claims abstract description 74
210000002219 extraembryonic membrane Anatomy 0.000 title description 8
102000008186 Collagen Human genes 0.000 claims abstract description 29
108010035532 Collagen Proteins 0.000 claims abstract description 29
229920001436 collagen Polymers 0.000 claims abstract description 29
238000000034 method Methods 0.000 claims abstract description 19
210000002826 placenta Anatomy 0.000 claims abstract description 15
210000004204 blood vessel Anatomy 0.000 claims abstract description 7
210000001691 amnion Anatomy 0.000 claims description 53
210000004379 membrane Anatomy 0.000 claims description 21
239000012528 membrane Substances 0.000 claims description 21
210000002469 basement membrane Anatomy 0.000 claims description 19
210000001136 chorion Anatomy 0.000 claims description 19
102000016359 Fibronectins Human genes 0.000 claims description 8
108010067306 Fibronectins Proteins 0.000 claims description 8
238000005304 joining Methods 0.000 claims description 7
108010025020 Nerve Growth Factor Proteins 0.000 claims description 5
230000032798 delamination Effects 0.000 claims description 4
239000000203 mixture Substances 0.000 claims description 3
210000003722 extracellular fluid Anatomy 0.000 claims description 2
102000015336 Nerve Growth Factor Human genes 0.000 claims 2
229940053128 nerve growth factor Drugs 0.000 claims 2
230000008929 regeneration Effects 0.000 abstract description 12
238000011069 regeneration method Methods 0.000 abstract description 12
210000003050 axon Anatomy 0.000 abstract description 9
230000002163 immunogen Effects 0.000 abstract description 3
238000004519 manufacturing process Methods 0.000 abstract description 2
239000010410 layer Substances 0.000 description 17
239000000463 material Substances 0.000 description 14
241001465754 Metazoa Species 0.000 description 10
102000007547 Laminin Human genes 0.000 description 9
108010085895 Laminin Proteins 0.000 description 9
230000001605 fetal effect Effects 0.000 description 8
230000002792 vascular Effects 0.000 description 8
102000004142 Trypsin Human genes 0.000 description 6
108090000631 Trypsin Proteins 0.000 description 6
239000012588 trypsin Substances 0.000 description 6
210000003462 vein Anatomy 0.000 description 6
102000003886 Glycoproteins Human genes 0.000 description 5
108090000288 Glycoproteins Proteins 0.000 description 5
230000003376 axonal effect Effects 0.000 description 5
239000012153 distilled water Substances 0.000 description 5
210000003205 muscle Anatomy 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
230000001413 cellular effect Effects 0.000 description 4
230000005855 radiation Effects 0.000 description 4
230000008521 reorganization Effects 0.000 description 4
210000002972 tibial nerve Anatomy 0.000 description 4
210000001519 tissue Anatomy 0.000 description 4
241000283690 Bos taurus Species 0.000 description 3
241000282326 Felis catus Species 0.000 description 3
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
102000007072 Nerve Growth Factors Human genes 0.000 description 3
238000011161 development Methods 0.000 description 3
230000018109 developmental process Effects 0.000 description 3
239000003292 glue Substances 0.000 description 3
230000028993 immune response Effects 0.000 description 3
238000002513 implantation Methods 0.000 description 3
230000008595 infiltration Effects 0.000 description 3
238000001764 infiltration Methods 0.000 description 3
238000012545 processing Methods 0.000 description 3
230000001172 regenerating effect Effects 0.000 description 3
230000008439 repair process Effects 0.000 description 3
229920002379 silicone rubber Polymers 0.000 description 3
239000004945 silicone rubber Substances 0.000 description 3
208000030507 AIDS Diseases 0.000 description 2
238000002965 ELISA Methods 0.000 description 2
108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 2
206010029113 Neovascularisation Diseases 0.000 description 2
206010029174 Nerve compression Diseases 0.000 description 2
102000057297 Pepsin A Human genes 0.000 description 2
108090000284 Pepsin A Proteins 0.000 description 2
208000007536 Thrombosis Diseases 0.000 description 2
241000700605 Viruses Species 0.000 description 2
230000001154 acute effect Effects 0.000 description 2
239000000427 antigen Substances 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
238000010382 chemical cross-linking Methods 0.000 description 2
230000001684 chronic effect Effects 0.000 description 2
210000002808 connective tissue Anatomy 0.000 description 2
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000003814 drug Substances 0.000 description 2
239000003102 growth factor Substances 0.000 description 2
230000001900 immune effect Effects 0.000 description 2
230000005847 immunogenicity Effects 0.000 description 2
210000004969 inflammatory cell Anatomy 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
102000006495 integrins Human genes 0.000 description 2
108010044426 integrins Proteins 0.000 description 2
230000005541 medical transmission Effects 0.000 description 2
230000000877 morphologic effect Effects 0.000 description 2
230000000508 neurotrophic effect Effects 0.000 description 2
239000002245 particle Substances 0.000 description 2
229940111202 pepsin Drugs 0.000 description 2
230000002093 peripheral effect Effects 0.000 description 2
210000000578 peripheral nerve Anatomy 0.000 description 2
239000002953 phosphate buffered saline Substances 0.000 description 2
102000005962 receptors Human genes 0.000 description 2
108020003175 receptors Proteins 0.000 description 2
238000007634 remodeling Methods 0.000 description 2
238000011160 research Methods 0.000 description 2
239000002356 single layer Substances 0.000 description 2
239000000243 solution Substances 0.000 description 2
238000007920 subcutaneous administration Methods 0.000 description 2
238000001356 surgical procedure Methods 0.000 description 2
238000012360 testing method Methods 0.000 description 2
230000003612 virological effect Effects 0.000 description 2
206010002091 Anaesthesia Diseases 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
102000012422 Collagen Type I Human genes 0.000 description 1
108010022452 Collagen Type I Proteins 0.000 description 1
102000001187 Collagen Type III Human genes 0.000 description 1
108010069502 Collagen Type III Proteins 0.000 description 1
229920004934 Dacron® Polymers 0.000 description 1
241000233866 Fungi Species 0.000 description 1
208000035154 Hyperesthesia Diseases 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 description 1
229920001710 Polyorthoester Polymers 0.000 description 1
241000700159 Rattus Species 0.000 description 1
239000004809 Teflon Substances 0.000 description 1
229920006362 Teflon® Polymers 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
230000037005 anaesthesia Effects 0.000 description 1
238000010171 animal model Methods 0.000 description 1
210000001367 artery Anatomy 0.000 description 1
230000028600 axonogenesis Effects 0.000 description 1
230000017531 blood circulation Effects 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
210000004027 cell Anatomy 0.000 description 1
210000004298 cerebral vein Anatomy 0.000 description 1
229940096422 collagen type i Drugs 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000011109 contamination Methods 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
230000007547 defect Effects 0.000 description 1
229940080861 demerol Drugs 0.000 description 1
238000002224 dissection Methods 0.000 description 1
238000009826 distribution Methods 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
BCQZXOMGPXTTIC-UHFFFAOYSA-N halothane Chemical compound FC(F)(F)C(Cl)Br BCQZXOMGPXTTIC-UHFFFAOYSA-N 0.000 description 1
229960003132 halothane Drugs 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
239000003018 immunosuppressive agent Substances 0.000 description 1
229940125721 immunosuppressive agent Drugs 0.000 description 1
230000006872 improvement Effects 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000036512 infertility Effects 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
230000001678 irradiating effect Effects 0.000 description 1
230000007774 longterm Effects 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
239000003900 neurotrophic factor Substances 0.000 description 1
230000001453 nonthrombogenic effect Effects 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
230000032696 parturition Effects 0.000 description 1
DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
239000002745 poly(ortho ester) Substances 0.000 description 1
239000005020 polyethylene terephthalate Substances 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
229920001343 polytetrafluoroethylene Polymers 0.000 description 1
239000004810 polytetrafluoroethylene Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
230000008569 process Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
238000009877 rendering Methods 0.000 description 1
238000005096 rolling process Methods 0.000 description 1
230000037390 scarring Effects 0.000 description 1
210000004116 schwann cell Anatomy 0.000 description 1
229910001220 stainless steel Inorganic materials 0.000 description 1
239000010935 stainless steel Substances 0.000 description 1
239000007858 starting material Substances 0.000 description 1
238000003860 storage Methods 0.000 description 1
210000001644 umbilical artery Anatomy 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/005—Ingredients of undetermined constitution or reaction products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
- A61L31/044—Collagen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
- A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/32—Materials or treatment for tissue regeneration for nerve reconstruction

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Oral & Maxillofacial Surgery (AREA)
Transplantation (AREA)
Vascular Medicine (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Medicinal Chemistry (AREA)
Dermatology (AREA)
Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Botany (AREA)
Urology & Nephrology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Prostheses (AREA)
Materials For Medical Uses (AREA)
Graft Or Block Polymers (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

CA002124190A 1991-11-26 1992-11-25 Tubes de membrane foetale pour greffes nerveuses et vasculaires Abandoned CA2124190A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US79951791A	1991-11-26	1991-11-26
US799,517		1991-11-26

Publications (1)

Publication Number	Publication Date
CA2124190A1 true CA2124190A1 (fr)	1993-06-10

Family

ID=25176121

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002124190A Abandoned CA2124190A1 (fr)	1991-11-26	1992-11-25	Tubes de membrane foetale pour greffes nerveuses et vasculaires

Country Status (13)

Country	Link
EP (1)	EP0614345A4 (fr)
JP (1)	JPH07501465A (fr)
CN (1)	CN1079912A (fr)
AU (1)	AU663150B2 (fr)
CA (1)	CA2124190A1 (fr)
FI (1)	FI942425L (fr)
IL (1)	IL103893A (fr)
NO (1)	NO941917L (fr)
NZ (1)	NZ245286A (fr)
RU (1)	RU94028108A (fr)
TW (1)	TW310273B (fr)
WO (1)	WO1993010722A2 (fr)
ZA (1)	ZA929119B (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9400163D0 (en) *	1994-01-06	1994-03-02	Geistlich Soehne Ag	Membrane
US6334872B1 (en)	1994-02-18	2002-01-01	Organogenesis Inc.	Method for treating diseased or damaged organs
US5834029A (en) *	1994-07-20	1998-11-10	Cytotherapeutics, Inc.	Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
GB9503492D0 (en)	1995-02-22	1995-04-12	Ed Geistlich S Hne A G F R Che	Chemical product
CA2173508A1 (fr) *	1995-03-31	1996-10-01	Tooru Yui	Dispositif medical et procede d'obtention
US5733337A (en) *	1995-04-07	1998-03-31	Organogenesis, Inc.	Tissue repair fabric
US20020095218A1 (en)	1996-03-12	2002-07-18	Carr Robert M.	Tissue repair fabric
JPH09122225A (ja) *	1995-10-31	1997-05-13	Bio Eng Lab:Kk	医用材料の原料膜材およびその製造方法
JPH09122227A (ja) *	1995-10-31	1997-05-13	Bio Eng Lab:Kk	医用材料およびその製造方法
JP3476631B2 (ja) *	1995-12-21	2003-12-10	株式会社アムニオテック	ヒト由来の天然コラーゲン膜からなる医用材料
TW528600B (en) *	1996-11-20	2003-04-21	Yasuhiko Shimizu	Artificial neural canal
US20050186283A1 (en)	1997-10-10	2005-08-25	Ed. Geistlich Soehne Ag Fuer Chemistrie Industrie	Collagen carrier of therapeutic genetic material, and method
US8858981B2 (en)	1997-10-10	2014-10-14	Ed. Geistlich Soehne Fuer Chemistrie Industrie	Bone healing material comprising matrix carrying bone-forming cells
US9034315B2 (en)	1997-10-10	2015-05-19	Ed. Geistlich Soehne Ag Fuer Chemische Industrie	Cell-charged multi-layer collagen membrane
CN1101704C (zh) *	1998-05-28	2003-02-19	南京市鼓楼医院	用人脐动脉作为血管移植物的制备工艺
CA2334364C (fr)	1998-06-05	2011-01-04	Organogenesis Inc.	Protheses pour greffes, genetiquement modifiees pour greffes se presentant sous forme de feuilles plates
ES2323099T3 (es)	1998-06-05	2009-07-06	Organogenesis Inc.	Protesis de injerto tubulares producidas por bioingenieria.
CA2334228C (fr)	1998-06-05	2010-09-28	Organogenesis Inc.	Protheses vasculaires greffees obtenues par genie biomedical
JP4341050B2 (ja)	1998-06-05	2009-10-07	オルガノジェネシスインク．	生体工学により作成した血管移植片補綴
CN1304296A (zh) *	1998-06-10	2001-07-18	清水庆彦	人造神经管
CZ301649B6 (cs) *	2000-06-28	2010-05-12	Ed. Geistlich Soehne Ag Fur Chemische Industrie Incorporated Under The Laws Of Switzerland	Trubice pro regeneraci nervu a zpusob jejich výroby
US6773723B1 (en) *	2000-08-30	2004-08-10	Depuy Acromed, Inc.	Collagen/polysaccharide bilayer matrix
US6713085B2 (en)	2001-04-27	2004-03-30	Ed. Geistlich Soehne Ag Fuer Chemische Industrie	Method and membrane for mucosa regeneration
DE10141652B4 (de) *	2001-08-24	2011-04-07	Lts Lohmann Therapie-Systeme Ag	Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
WO2003020327A2 (fr) *	2001-09-06	2003-03-13	Bone Sa	Biomatériau collagène réticulé
CA2412012C (fr)	2001-11-20	2011-08-02	Ed. Geistlich Soehne Ag Fuer Chemische Industrie	Matrice extracellulaire resorbable contenant du collagene i et du collagene ii pour la reconstruction de cartilage
CN100368534C (zh) *	2003-05-01	2008-02-13	四川大学华西医院	生物衍生羊膜、复合生物衍生羊膜及其制备方法
CN1986001B (zh) *	2005-12-20	2011-09-14	广东冠昊生物科技股份有限公司	生物护创膜
US8372437B2 (en)	2006-08-17	2013-02-12	Mimedx Group, Inc.	Placental tissue grafts
EP4559488A3 (fr)	2007-09-07	2025-08-13	MiMedx Group, Inc.	Greffons de tissu placentaire et procédés améliorés de préparation et d'utilisation de ceux-ci
US20110152898A1 (en) *	2008-05-09	2011-06-23	The General Hospital Corporation	Tissue engineered constructs
KR102118457B1 (ko)	2011-02-14	2020-06-03	미메딕스 그룹 인크.	가교제로 변형된 조직 이식편 및 그것의 제조 및 사용 방법
KR20140114277A (ko) *	2011-02-14	2014-09-26	미메딕스 그룹 인크.	바르톤 젤리로 이루어진 라미네이트된 조직 이식편 및 그것의 제조 및 사용 방법
US9585983B1 (en)	2011-10-12	2017-03-07	BioDlogics, LLC	Wound covering and method of preparation
CA2857636C (fr)	2011-12-22	2020-06-23	Mimedx Group Inc.	Greffes de tissu placentaire deshydratees reticulees et procedes pour fabriquer et utiliser celles-ci
US11338063B2 (en) *	2012-08-15	2022-05-24	Mimedx Group, Inc.	Placental tissue grafts modified with a cross-linking agent and methods of making and using the same
US9789138B1 (en)	2013-03-06	2017-10-17	BioDlogics, LLC	Neural repair construct and method of use
EP3349812B1 (fr)	2015-09-17	2021-01-06	Stimlabs LLC	Compositions dérivées de placenta et procédés pour les produire
US11154641B2 (en)	2017-12-22	2021-10-26	Stimlabs Llc	Translucent, dehydrated placental tissue and methods of producing and using the same
CN113304321B (zh) *	2021-06-01	2022-08-26	山东隽秀生物科技股份有限公司	一种生物膜材料及其制备方法与在修复神经中的应用
US11925532B2 (en)	2021-12-10	2024-03-12	Vivex Biologics Group, Inc.	Vented wound dressing barrier
AU2023299174A1 (en)	2022-06-29	2025-01-16	Biostem Technologies, Inc.	Sterile human placental allografts having a plurality of slits, openings, and/or fenestrations formed thereon
USD1085425S1 (en)	2022-11-18	2025-07-22	Biostem Technologies, Inc.	Fenestrated human placental allograft
USD1085424S1 (en)	2022-11-18	2025-07-22	Biostem Technologies, Inc.	Fenestrated human placental allograft

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL47062A (en) *	1975-04-10	1979-07-25	Yeda Res & Dev	Process for diminishing antigenicity of tissues to be usedas transplants by treatment with glutaraldehyde
US4894063A (en) *	1983-05-24	1990-01-16	Baxter International Inc.	Barrier layer for implantable tendons and ligaments
US5019087A (en) *	1986-10-06	1991-05-28	American Biomaterials Corporation	Nerve regeneration conduit
GB8803697D0 (en) *	1988-02-17	1988-03-16	Deltanine Research Ltd	Clinical developments using amniotic membrane cells
US5026381A (en) *	1989-04-20	1991-06-25	Colla-Tec, Incorporated	Multi-layered, semi-permeable conduit for nerve regeneration comprised of type 1 collagen, its method of manufacture and a method of nerve regeneration using said conduit

1992
- 1992-11-25 AU AU32245/93A patent/AU663150B2/en not_active Ceased
- 1992-11-25 CA CA002124190A patent/CA2124190A1/fr not_active Abandoned
- 1992-11-25 JP JP5510233A patent/JPH07501465A/ja active Pending
- 1992-11-25 RU RU94028108/14A patent/RU94028108A/ru unknown
- 1992-11-25 FI FI942425A patent/FI942425L/fi not_active Application Discontinuation
- 1992-11-25 EP EP19930900646 patent/EP0614345A4/fr not_active Ceased
- 1992-11-25 ZA ZA929119A patent/ZA929119B/xx unknown
- 1992-11-25 WO PCT/US1992/010165 patent/WO1993010722A2/fr not_active Ceased
- 1992-11-26 NZ NZ245286A patent/NZ245286A/en unknown
- 1992-11-26 IL IL10389392A patent/IL103893A/xx not_active IP Right Cessation
- 1992-11-26 CN CN92114817A patent/CN1079912A/zh active Pending
- 1992-12-15 TW TW081110056A patent/TW310273B/zh active
1994
- 1994-05-24 NO NO941917A patent/NO941917L/no unknown

Also Published As

Publication number	Publication date
TW310273B (fr)	1997-07-11
IL103893A0 (en)	1993-04-04
IL103893A (en)	1997-02-18
ZA929119B (en)	1994-09-21
NO941917D0 (no)	1994-05-24
EP0614345A4 (fr)	1994-12-07
WO1993010722A2 (fr)	1993-06-10
JPH07501465A (ja)	1995-02-16
EP0614345A1 (fr)	1994-09-14
AU663150B2 (en)	1995-09-28
AU3224593A (en)	1993-06-28
RU94028108A (ru)	1996-06-20
NZ245286A (en)	1995-06-27
NO941917L (no)	1994-05-24
FI942425A0 (fi)	1994-05-25
FI942425A7 (fi)	1994-05-25
CN1079912A (zh)	1993-12-29
WO1993010722A3 (fr)	1993-06-24
FI942425L (fi)	1994-05-25

Legal Events

Date	Code	Title	Description
1998-11-25	FZDE	Discontinued

Publication	Publication Date	Title
AU663150B2 (en)	1995-09-28	Fetal membrane tubes for nerve and vessel grafts
US4120649A (en)	1978-10-17	Transplants
CN101903050B (zh)	2013-07-24	各向异性植入物及其制造方法
DE60133377T2 (de)	2009-01-02	Dezellularisierte gefässprothesen
US20050159822A1 (en)	2005-07-21	Particulate acellular tissue matrix
US20140186461A1 (en)	2014-07-03	Human Amniotic Membrane Lyophilized Grafts
EP2282749A1 (fr)	2011-02-16	Pansement barrière antiadhésif comprenant un tissu amniotique traité et procédé d utilisation
EP0160025A1 (fr)	1985-11-06	Biomateriau.
JPH08502917A (ja)	1996-04-02	組織等価物
Eskeland et al.	1977	The ultrastructure of normal digital flexor tendon sheath and of the tissue formed around silicone and polyethylene implants in man
Schultheiss et al.	2000	Tissue engineering from Adam to the zygote: historical reflections
Kane et al.	1996	7.10 Burn Dressings
EP1123122B1 (fr)	2008-01-02	Materiau pour implant
Griffiths et al.	1982	Human dermal collagen allografts: a three year histological study
US7294144B1 (en)	2007-11-13	Preserved implantable vessel derived from a human umbilical cord or placenta
Noishiki et al.	1993	Development and evaluation of a pliable biological valved conduit. Part I: preparation, biochemical properties, and histological findings
CN116350855A (zh)	2023-06-30	一种胶原纤维定向排列的卷轴型神经导管及其制备方法和应用
CN119345438B (zh)	2025-05-09	一种脱细胞外基质生物型敷料及其制备方法
JP2000262610A (ja)	2000-09-26	表皮再生を目的とした自家抜去毛包移植用の人工真皮
CA3225805C (fr)	2026-03-17	Procede d'acquisition et d'utilisation de tissu pour allogreffes
KR20180078625A (ko)	2018-07-10	콜라겐 멤브레인 및 이의 제조방법
US20170080127A1 (en)	2017-03-23	Biologically active graft for skin replacement therapy
Shapiro et al.	1978	Surface chemistry characteristics of human umbilical vein used as chronic canine arteriovenous fistulas
WO2023196787A2 (fr)	2023-10-12	Tissu construit amélioré
AU2024205144B1 (en)	2024-12-19	Crosslinked amniotic membrane material, preparation method therefore, and applications thereof